Hospira Australia Pty, Limited

FDA inspection history in Mulgrave, Australia, 2014 to 2022

1
Form 483
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2014: one warning letter; 2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2014One warning letter, at Mulgrave, Australia.
  2. 2022One Form 483, at Mulgrave, Australia.

Cited most

Across all Hospira Australia Pty, Limited observations on file

The complete Hospira Australia Pty, Limited file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2022-09-02483 Form 483$99
2014-09-26Warning letter Warning letter$99

Investigators on these documents

Michele L. Glendenning (1)

FEI number 3001174929 · most recent document Sep 2, 2022

About Hospira Australia Pty, Limited

How many FDA Form 483s has Hospira Australia Pty, Limited received?

FDA Intel has 1 Form 483 on file for Hospira Australia Pty, Limited; the most recent is dated Sep 2, 2022.

When was Hospira Australia Pty, Limited last inspected by FDA?

The most recent FDA inspection document on file for Hospira Australia Pty, Limited is a Form 483 dated Sep 2, 2022, for the site in Mulgrave, Australia.

What did FDA cite at Hospira Australia Pty, Limited?

The regulations cited most in the observations on file for Hospira Australia Pty, Limited are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time.

Has Hospira Australia Pty, Limited received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Hospira Australia Pty, Limited; the most recent is dated Sep 26, 2014.